Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x107px
Organisation › Details

Sanofi (Group) [since May 2011]

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

Period Start 2011-05-06 renamed
Product Industry pharmaceutical
     
  Street 174 avenue de France
  City 75635 Paris
  Tel +33-1-5377-4000
    Address record changed: 2012-01-11
     
Basic data Employees I: 50,001 to 100,0 (2005-12-31)
  Currency EUR
  Annual sales 34,542,000,000 (sales, net, consolidated (2015) 2015-12-31)
  Profit 4,287,000,000 (2015-12-31)
  Cash 9,148,000,000 (2015-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2017-11-17

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

More documents for Sanofi (Group) [since May 2011]


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2018 Boston Partnering 560x80px




» top